Biomerieux SA (BIOX.PA)
BIOX.PA on Paris Stock Exchange
72.40EUR
18 Apr 2019
72.40EUR
18 Apr 2019
Change (% chg)
€-0.40 (-0.55%)
€-0.40 (-0.55%)
Prev Close
€72.80
€72.80
Open
€72.50
€72.50
Day's High
€72.75
€72.75
Day's Low
€71.55
€71.55
Volume
179,497
179,497
Avg. Vol
93,968
93,968
52-wk High
€82.60
€82.60
52-wk Low
€53.10
€53.10
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 1,252.10 | 1.030 |
| Jun '18 | 1,169.20 | 1.140 | |
| FY 2017 | Dec '17 | 1,153.90 | 1.162 |
| Jun '17 | 1,134.30 | 0.854 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 1 | 1,263.00 | 1,263.00 | 1,263.00 | -- |
| Quarter Ending Dec-19 | 2 | 1,963.40 | 2,583.00 | 1,343.80 | 2,583.00 |
| Year Ending Dec-19 | 11 | 2,624.75 | 2,678.00 | 2,546.00 | 2,580.43 |
| Year Ending Dec-20 | 11 | 2,807.53 | 2,882.00 | 2,749.70 | 2,768.60 |
| Earnings (per share) | |||||
| Year Ending Dec-19 | 11 | 2.31 | 2.43 | 2.22 | 2.20 |
| Year Ending Dec-20 | 11 | 2.63 | 2.80 | 2.44 | 2.55 |
| LT Growth Rate (%) | 2 | 8.80 | 10.90 | 6.70 | 13.40 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 33.36 | 33.35 | 62.40 | |
| P/E High - Last 5 Yrs. | 39.24 | 39.26 | 56.31 | |
| P/E Low - Last 5 Yrs. | 25.07 | 23.99 | 28.72 | |
| Beta | 0.55 | 0.79 | 0.93 | |
| Price to Sales (TTM) | 3.54 | 6.00 | 9.62 | |
| Price to Book (MRQ) | 4.42 | 4.69 | 4.53 | |
| Price to Tangible Book (MRQ) | 10.64 | 8.22 | 7.71 | |
| Price to Cash Flow (TTM) | 19.96 | 22.67 | 43.23 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.48 | 1.07 | 1.54 | |
| Dividend Yield - 5 Year Avg | 0.69 | 1.16 | 0.70 | |
| Dividend 5 Year Growth Rate | 0.98 | 15.16 | 2.97 | |
| Payout Ratio(TTM) | 16.13 | 32.09 | 21.72 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 8.51 | 15.12 | 9.20 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 5.82 | 5.91 | 8.35 | |
| Sales - 5 Yr. Growth Rate | 8.80 | 9.60 | 11.12 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -11.31 | -21.65 | 110.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 7.65 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 9.37 | 14.42 | 6.92 | |
| Capital Spending - 5 Yr. Growth Rate | 11.59 | 5.01 | 7.61 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.16 | 2.31 | 2.66 |
| Current Ratio (MRQ) | 1.71 | 3.01 | 3.63 |
| LT Debt to Equity (MRQ) | 23.16 | 19.69 | 13.26 |
| Total Debt to Equity (MRQ) | 28.35 | 26.03 | 16.97 |
| Interest Coverage (TTM) | 13.63 | 27.55 | 27.27 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 53.78 | 59.10 | 50.31 | |
| Gross Margin - 5 Yr. Avg. | 51.97 | 58.45 | 50.77 | |
| EBITD Margin (TTM) | 21.37 | -- | -- | |
| EBITD - 5 Yr. Avg | 20.17 | 23.65 | 15.78 | |
| Operating Margin (TTM) | 14.19 | 18.15 | -2.09 | |
| Operating Margin - 5 Yr. Avg. | 12.83 | 16.39 | 11.11 | |
| Pre-Tax Margin (TTM) | 13.24 | 17.65 | -2.92 | |
| Pre-Tax Margin - 5 Yr. Avg. | 11.80 | 16.37 | 16.76 | |
| Net Profit Margin (TTM) | 10.55 | 13.20 | -6.86 | |
| Net Profit Margin - 5 Yr. Avg. | 8.78 | 11.70 | 11.72 | |
| Effective Tax Rate (TTM) | 20.34 | 24.84 | 22.86 | |
| Effective Tax Rate - 5 Yr. Avg. | 25.64 | 27.32 | 23.86 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 218,253 | 30,063,466 | 773,166,387 | |
| Net Income/Employee (TTM) | 23,021 | 3,034,632 | 89,056,262 | |
| Receivable Turnover (TTM) | 5.10 | 4.89 | 5.22 | |
| Inventory Turnover (TTM) | 2.81 | 3.01 | 3.65 | |
| Asset Turnover (TTM) | 0.76 | 0.75 | 0.81 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 8.01 | 9.85 | 9.54 | |
| Return on Assets - 5 Yr. Avg. | 6.49 | 9.07 | 10.49 | |
| Return on Investment (TTM) | 10.43 | 12.70 | 11.78 | |
| Return on Investment - 5 Yr. Avg. | 8.53 | 11.74 | 13.39 | |
| Return on Equity (TTM) | 14.00 | 14.94 | 12.61 | |
| Return on Equity - 5 Yr. Avg. | 11.74 | 15.37 | 14.86 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 5.82 | 7.22 | 8.80 |
| EPS (TTM) % | 7.66 | 32.46 | 9.37 |
| Dividend % | 2.94 | 1.64 | 0.98 |
Note: Units in Millions of US Dollars
Performance for Biomerieux SA
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -1.23 | -4.79 | 99 | 7 |
| 13 Week | 20.87 | 3.84 | 99 | 59 |
| 26 Week | 9.53 | 0.43 | 99 | 22 |
| 52 Week | 4.32 | 0.58 | 99 | 63 |
| YTD | 25.91 | 6.74 | 99 | 47 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 19.27% |
| # of Holders: | 237 |
| Total Shares Held: | 22,812,405 |
| 3 Mo. Net Change: | 198,579 |
| # New Positions: | 8 |
| # Closed Positions: | 4 |
| # Increased Positions: | 51 |
| # Reduced Positions: | 46 |
| # Net Buyers: | 5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.